{"id":17573,"date":"2025-08-22T09:00:16","date_gmt":"2025-08-22T13:00:16","guid":{"rendered":"https:\/\/okdiario.com\/metabolic\/en\/?p=17573"},"modified":"2026-04-27T12:38:32","modified_gmt":"2026-04-27T17:38:32","slug":"taking-blood-pressure-medication-at-night-improves-day-and-night-control-clinical-trial-finds","status":"publish","type":"post","link":"https:\/\/okdiario.com\/metabolic\/en\/uncategorized\/taking-blood-pressure-medication-at-night-improves-day-and-night-control-clinical-trial-finds-17573\/","title":{"rendered":"Taking blood pressure medication at night improves day and night control, clinical trial finds"},"content":{"rendered":"

A new clinical trial suggests that taking blood pressure medicine at night may improve control of both nighttime and daytime readings<\/strong>. The results could change how some people with hypertension manage their treatment<\/a><\/strong>.<\/p>\n

Researchers from Sichuan University in China compared morning versus bedtime dosing of antihypertensive drugs. They found bedtime use lowered nighttime blood pressure more effectively without increasing side effects<\/strong>. Here, we’ll break down the study, what the numbers mean, and how the findings could be applied in daily care for people with high blood pressure<\/strong><\/a>.<\/p>\n

Bedtime dosing showed better blood pressure results<\/h2>\n

Hypertension is a major health problem worldwide and a key risk factor for heart attack and stroke. Nocturnal blood pressure is especially important because high nighttime readings are linked to a greater risk of cardiovascular events<\/strong> than daytime readings. Yet for many patients, nighttime control is the most difficult to achieve.<\/p>\n

The trial, published in JAMA Network Open<\/strong><\/a>, enrolled 720 adults aged 18 to 75 who either had never been treated for hypertension or had stopped medication for at least two weeks. All participants were given a single-pill combination<\/strong> of olmesartan (20 mg) and amlodipine (5 mg), with doses adjusted every four weeks based on ambulatory and office blood pressure monitoring.<\/p>\n

Half the participants took their medication in the morning between 6:00 and 10:00 a.m. The other half took it at night between 6:00 and 10:00 p.m. After 12 weeks, the bedtime group saw an average nighttime systolic blood pressure drop that was 3 mm Hg greater than the morning group<\/strong>, along with a 1.4 mm Hg greater drop in nighttime diastolic pressure.<\/p>\n

Control rates for nighttime systolic pressure were 79% in the bedtime group<\/strong> compared with 69.8% in the morning group. Office readings also favored bedtime dosing, with 88.7% achieving target systolic control compared with 82.2% in the morning group. Morning blood pressure readings improved as well, and fewer patients in the bedtime group needed dose increases.<\/p>\n

In addition, the study found no rise in nocturnal hypotension or in reported side effects, suggesting bedtime dosing is well tolerated<\/strong>. Researchers noted that the improved control did not come at the expense of average daytime or 24-hour readings.<\/p>\n

How could this be applied in blood pressure treatment<\/h2>\n

These findings raise the possibility that adjusting the timing of blood pressure medication could help certain patients reach better control without changing their prescription<\/strong>. While this study tested only the olmesartan-amlodipine combination, the results support exploring bedtime dosing with other antihypertensive drug classes. Possible applications include:<\/p>\n